| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| GTO ID | GTC1871 |
| Trial ID | NCT03464916 |
| Disease | Multiple Myeloma |
| Altered gene | CD38 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD38 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients |
| Year | 2018 |
| Country | United States |
| Company sponsor | Sorrento Therapeutics, Inc. |
| Other ID(s) | SOR-CART-MM-001 |
| Cohort 1 | |||||||||
|
|||||||||